Biblio

Export 309 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Keyword is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
O
E. Oldoni, Fumagalli, G. G., Serpente, M., Fenoglio, C., Scarioni, M., Arighi, A., Bruno, G., Talarico, G., Confaloni, A., Piscopo, P., Nacmias, B., Sorbi, S., Rainero, I., Rubino, E., Pinessi, L., Binetti, G., Ghidoni, R., Benussi, L., Grande, G., Arosio, B., Bursey, D., Kauwe, J. S., Cioffi, S. Mg, Arcaro, M., Mari, D., Mariani, C., Scarpini, E., and Galimberti, D., “PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.”, J Alzheimers Dis, vol. 50, no. 2, pp. 353-7, 2016.
M. Ángel Ontiveros-Torres, Labra-Barrios, M. Luisa, Díaz-Cintra, S., Aguilar-Vázquez, A. Ruth, Moreno-Campuzano, S., Flores-Rodríguez, P., Luna-Herrera, C., Mena, R., Perry, G., Florán-Garduño, B., Luna-Muñoz, J., and Luna-Arias, J. Pedro, “Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.”, J Alzheimers Dis, vol. 52, no. 1, pp. 243-69, 2016.
N. Ortí-Casañ, Wajant, H., H Kuiperij, B., Hooijsma, A., Tromp, L., Poortman, I. L., Tadema, N., de Lange, J. H. E., Verbeek, M. M., De Deyn, P. P., Naudé, P. J. W., and Eisel, U. L. M., “Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.”, J Alzheimers Dis, vol. 94, no. 3, pp. 977-991, 2023.
A. Oulhaj, Jernerén, F., Refsum, H., A Smith, D., and de Jager, C. A., “Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 2, pp. 547-57, 2016.
P
M. Pacheco-Herrero, Soto-Rojas, L. O., Reyes-Sabater, H., Garcés-Ramirez, L., López, Fde la Cruz, Villanueva-Fierro, I., and Luna-Muñoz, J., “Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease.”, J Alzheimers Dis, vol. 84, no. 3, pp. 917-935, 2021.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
L. Pasquini, Scherr, M., Tahmasian, M., Myers, N. E., Ortner, M., Kurz, A., Förstl, H., Zimmer, C., Grimmer, T., Akhrif, A., Wohlschläger, A. M., Riedl, V., and Sorg, C., “Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 51, no. 1, pp. 313-26, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P., “MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”, J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
J. Peter, Schumacher, L. V., Landerer, V., Abdulkadir, A., Kaller, C. P., Lahr, J., and Klöppel, S., “Biological Factors Contributing to the Response to Cognitive Training in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 1, pp. 333-345, 2018.
I. Piaceri, Bessi, V., Matà, S., Polito, C., Tedde, A., Berti, V., Bagnoli, S., Braccia, A., Del Mastio, M., Pignone, A. Moggi, Pupi, A., Sorbi, S., and Nacmias, B., “Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline.”, J Alzheimers Dis, vol. 61, no. 1, pp. 41-46, 2018.
F. Piazza, Greenberg, S. M., Savoiardo, M., Gardinetti, M., Chiapparini, L., Raicher, I., Nitrini, R., Sakaguchi, H., Brioschi, M., Billo, G., Colombo, A., Lanzani, F., Piscosquito, G., Carriero, M. Rita, Giaccone, G., Tagliavini, F., Ferrarese, C., and DiFrancesco, J. C., “Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies.”, Ann Neurol, vol. 73, no. 4, pp. 449-58, 2013.
N. Pierrot, Lhommel, R., Quenon, L., Hanseeuw, B., Dricot, L., Sindic, C., Maloteaux, J. - M., Octavea, J. - N., and Ivanoiu, A., “Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 271-6, 2016.
N. Pierrot, Lhommel, R., Quenon, L., Hanseeuw, B., Dricot, L., Sindic, C., Maloteaux, J. - M., Octavea, J. - N., and Ivanoiu, A., “Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 271-6, 2016.
A. Pilotto, Turrone, R., Liepelt-Scarfone, I., Bianchi, M., Poli, L., Borroni, B., Alberici, A., Premi, E., Formenti, A., Bigni, B., Cosseddu, M., Cottini, E., Berg, D., and Padovani, A., “Vascular Risk Factors and Cognition in Parkinson's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 563-70, 2016.
E. C. Pinnock, Jovanovic, K., Pinto, M. G., Ferreira, E., Dias, B. Da Costa, Penny, C., Knackmuss, S., Reusch, U., Little, M., Schatzl, H. M., and Weiss, S. F. T., “LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 645-57, 2016.
R. Pluta, Kocki, J., Ułamek-Kozioł, M., Petniak, A., Gil-Kulik, P., Januszewski, S., Bogucki, J., Jabłoński, M., Brzozowska, J., Furmaga-Jabłońska, W., Bogucka-Kocka, A., and Czuczwar, S. J., “Discrepancy in Expression of β-Secretase and Amyloid-β Protein Precursor in Alzheimer-Related Genes in the Rat Medial Temporal Lobe Cortex Following Transient Global Brain Ischemia.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1023-31, 2016.
R. Pluta, Kocki, J., Ułamek-Kozioł, M., Petniak, A., Gil-Kulik, P., Januszewski, S., Bogucki, J., Jabłoński, M., Brzozowska, J., Furmaga-Jabłońska, W., Bogucka-Kocka, A., and Czuczwar, S. J., “Discrepancy in Expression of β-Secretase and Amyloid-β Protein Precursor in Alzheimer-Related Genes in the Rat Medial Temporal Lobe Cortex Following Transient Global Brain Ischemia.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1023-31, 2016.
S. Preethy, Ranganathan, N., Raghavan, K., Dedeepiya, V. Devaprasad, Ikewaki, N., and Abraham, S. J. K., “Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1451-1460, 2022.
E. Premi, Cauda, F., Costa, T., Diano, M., Gazzina, S., Gualeni, V., Alberici, A., Archetti, S., Magoni, M., Gasparotti, R., Padovani, A., and Borroni, B., “Looking for Neuroimaging Markers in Frontotemporal Lobar Degeneration Clinical Trials: A Multi-Voxel Pattern Analysis Study in Granulin Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 249-62, 2016.
Q
H. Qiu, Zhong, R., Liu, H., Zhang, F., Li, S., and Le, W., “Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AβPP(swe)/PS1(ΔE9) Mice.”, J Alzheimers Dis, vol. 50, no. 3, pp. 669-85, 2016.
D. J. Quintana-Hernández, Miró-Barrachina, M. T., Ibáñez-Fernández, I. J., Del Pino, A. Santana-, Quintana-Montesdeoca, M. P., de Vera, B. Rodríguez, Morales-Casanova, D., Pérez-Vieitez, M. Del Carmen, Rodríguez-García, J., and Bravo-Caraduje, N., “Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 50, no. 1, pp. 217-32, 2016.
R
S. Ramanan, Flanagan, E., Leyton, C. E., Villemagne, V. L., Rowe, C. C., Hodges, J. R., and Hornberger, M., “Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.”, J Alzheimers Dis, vol. 51, no. 2, pp. 367-76, 2016.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Page, R., Morrell, C., and Shea, T. B., “Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.”, J Alzheimers Dis, vol. 51, no. 4, pp. 991-5, 2016.
D. Renard, Collombier, L., Demattei, C., Wacongne, A., Charif, M., Ayrignac, X., Azakri, S., Gaillard, N., Boudousq, V., Lehmann, S., de Champfleur, N. Menjot, and Thouvenot, E., “Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1107-1117, 2018.
D. Renard, Wacongne, A., Ayrignac, X., Charif, M., Fourcade, G., Azakri, S., Le Floch, A., Bouly, S., Marelli, C., Arquizan, C., Hirtz, C., Gabelle, A., Thouvenot, E., and Lehmann, S., “Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 50, no. 3, pp. 759-64, 2016.

Pages